2-Chloro-8-ethyl-quinoline-3-carbaldehyde, 96.0%, 100mg

2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-10-one, 97.0%, 100mg

3-Bromobenzoic acid, 98.0%, 10g

3-Ethoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 1g

[3-(4-methylphenyl)oxetan-3-yl]methanol, 95.0%, 100mg

GC capillary column ROTI®Cap-1701, 50 m, 0.25 mm, 0.25 µm, 1 Piece(s)

4-oxo-1,2,5,6-tetrahydro-4H-pyrrolo[3,2,1-ij]quinoline-8-sulfonyl chloride, 95.0%, 1g

Benzyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate, 95.0%, 25g

2-(Aminosulfonyl)-4-iodobenzoic acid methyl ester, 98+%, 1g

(2E)-3-(5-methyl-2-furyl)acryloyl chloride, 5g

Test tube with flat bottom, 19 mm, Height, 50 mm, 100 Piece(s)

2-(2-fluorophenyl)-4'-iodoacetophenone, 97.0%, 5g

3-Nitropyrrole, 98.0%, 1g